Abstract |
|
Authors | Emil Lou, Ashley L Sumrall, Scott Turner, Katherine B Peters, Annick Desjardins, James J Vredenburgh, Roger E McLendon, James E Herndon 2nd, Frances McSherry, Julie Norfleet, Henry S Friedman, David A Reardon |
Journal | Journal of neuro-oncology
(J Neurooncol)
Vol. 109
Issue 1
Pg. 63-70
(Aug 2012)
ISSN: 1573-7373 [Electronic] United States |
PMID | 22535433
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal, Humanized
- Bevacizumab
|
Topics |
- Adult
- Aged
- Angiogenesis Inhibitors
(therapeutic use)
- Antibodies, Monoclonal, Humanized
(therapeutic use)
- Bevacizumab
- Female
- Follow-Up Studies
- Humans
- Magnetic Resonance Imaging
- Male
- Meningeal Neoplasms
(drug therapy, mortality, pathology)
- Meningioma
(drug therapy, mortality, pathology)
- Middle Aged
- Neoplasm Recurrence, Local
(drug therapy, mortality, pathology)
- Neoplasm Staging
- Prognosis
- Retrospective Studies
- Survival Rate
- Young Adult
|